• Explore /
  • Poster
  • / A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy.

A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy.

Abstract Poster

Authors

null

William R Gwin III

University of Washington, Cancer Vaccine Institute, Seattle, WA

William R Gwin III, Kristin Kuano , Jennifer Childs , Lynn Katherine Symonds , Andrew L. Coveler , John B. Liao , Shaveta Vinayak , Mary L. Disis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Clinical Trial Registration Number

NCT04329065

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS636)

DOI

10.1200/JCO.2023.41.16_suppl.TPS636

Abstract #

TPS636

Poster Bd #

455b

Abstract Disclosures

Similar Posters

First Author: Jennifer Gao

First Author: Nicholas Patrick McAndrew

First Author: Timothy Jay Price

First Author: Sayeh Moazami Lavasani